Increased S100B Levels in Cannabis Use Disorder

2015 ◽  
Vol 22 (4) ◽  
pp. 177-180 ◽  
Author(s):  
Huseyin Bayazit ◽  
Erdinc Cicek ◽  
Salih Selek ◽  
Nurten Aksoy ◽  
I. Fatih Karababa ◽  
...  
Keyword(s):  
Calcium Binding ◽  
Neuronal Damage ◽  
Cannabis Use ◽  
S100b Protein ◽  
Control Group ◽  
Blood Levels ◽  
Cannabis Use Disorder ◽  
Protein Levels ◽  
S100 Calcium Binding Protein ◽  
The Mean

Background: It has been determined that cannabis has adverse effects on brain tissue, and that increased S100 calcium binding protein B (S100B) blood levels are markers of neuronal damage. Therefore, the aim of this study was to evaluate the S100B levels in cannabis use disorder. Method: Thirty-two patients with cannabis use disorder and 31 matched healthy controls were enrolled in this study. Appropriate blood samples were taken from the enrolled subjects, and the serum S100B protein levels were measured with an electrochemiluminescence immunoassay for the quantification of the protein. Findings: We found significantly increased S100B protein levels in patients with cannabis use disorder. The mean serum concentration of S100B was 0.081 ± 0.018 μg/l in patients with cannabis use disorder, and 0.069 ± 0.018 μg/l in the control group (p = 0.008). Interpretation: Our data suggest that elevated S100B protein levels might indicate neuronal damage in the brains of people with cannabis use disorder.

scholarly journals Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary Observation

2002 ◽  
Vol 9 (1) ◽  
pp. 164-166 ◽  
Author(s):  
Luis V. C. Portela ◽  
João C. T. Brenol ◽  
Roger Walz ◽  
Marino Bianchin ◽  
Adriano B. L. Tort ◽  
...  
Keyword(s):  
Lupus Erythematosus ◽  
Calcium Binding ◽  
Blood Donors ◽  
Biochemical Marker ◽  
S100b Protein ◽  
Control Group ◽  
Cns Involvement ◽  
Serum S100b ◽  
Protein Levels ◽  
Significant Difference

ABSTRACT S100B is an astrocytic calcium-binding protein which has been proposed as a biochemical marker of brain damage or dysfunction in acute and chronic diseases. We investigated whether serum S100B levels could be related to systemic lupus erythematosus (SLE) activity. Patients were grouped as having inactive SLE (ISLE), active SLE without central nervous system (CNS) involvement (ASLE), or active SLE with unequivocal neurologic or psychiatric manifestation (NPSLE). The control group consisted of age- and sex-matched healthy blood donors. S100B levels were determined using a luminescence immunoassay. All SLE groups had higher levels of serum S100B than the control group. Among the SLE groups, significantly higher levels of serum S100B protein were found in the NPSLE group than in the ISLE and ASLE groups, and there was no significant difference in S100B levels between the ISLE and ASLE groups. These preliminary results point to a putative relevance of serum S100B protein levels in SLE patients, specifically concerning CNS involvement present in this disease.

The association between cannabis use disorder and the outcome following primary total hip arthroplasty

2021 ◽  
Vol 103-B (7 Supple B) ◽  
pp. 111-115
Author(s):  
Rushabh M. Vakharia ◽  
Angelo Mannino ◽  
Hytham S. Salem ◽  
Martin W. Roche ◽  
Che Hang J. Wong ◽  
...  
Keyword(s):  
Total Hip Arthroplasty ◽  
Hip Arthroplasty ◽  
Cannabis Use ◽  
Hospital Length Of Stay ◽  
Medical Complications ◽  
Control Group ◽  
Study Group ◽  
Cannabis Use Disorder ◽  
Total Hip ◽  
Primary Total Hip Arthroplasty

Aims Although there is increasing legalization of the use of cannabis in the USA, few well-powered studies have evaluated the association between cannabis use disorder and outcomes following primary total hip arthroplasty (THA). Thus, the aim of this study was to determine whether patients who use cannabis and undergo primary THA have higher rates of in-hospital length of stay (LOS), medical complications, implant-related complications, and costs. Methods Using an administrative database, patients with cannabis use disorder undergoing primary THA were matched to a control group in a 1:5 ratio by age, sex, and various medical comorbidities. This yielded 23,030 patients (3,842 in the study group matched with 19,188 in the control group). The variables which were studied included LOS, 90-day medical complications, two-year implant-related complications, and 90-day costs of care. Mann-Whitney U tests were used to compare LOS and costs. Multivariate logistic regression analyses were used to calculate the odds ratios (ORs) of developing complications. Results We found that patients in the study group had a significantly longer mean LOS compared with the controls (four days vs three days; p < 0.0001).The study group also had a significantly higher incidence and odds of developing medical (23.0 vs 9.8%, OR 1.6; p < 0.0001) and implant-related complications (16 vs 7.4%, OR 1.6; p < 0.0001) and incurred significantly higher mean 90-day costs ($16,938.00 vs $16,023.00; p < 0.0001). Conclusion With the increasing rates of cannabis use, these findings allow orthopaedic surgeons and other healthcare professionals to counsel patients with cannabis use disorder about the possible outcomes following their THA, with increased hospital stays, complications, and costs. Cite this article: Bone Joint J 2021;103-B(7 Supple B):111–115.

scholarly journals Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients

Molecules ◽  
2021 ◽  
Vol 26 (17) ◽  
pp. 5311
Author(s):  
Fawaz Alasmari ◽  
Sary Alsanea ◽  
Assim A. Alfadda ◽  
Ibrahim O. Alanazi ◽  
Mohthash Musambil ◽  
...  
Keyword(s):  
Signaling Pathways ◽  
Proteomic Analysis ◽  
Cannabis Use ◽  
Farnesoid X Receptor ◽  
Differentially Expressed ◽  
Interleukin 12 ◽  
Control Group ◽  
Cannabis Use Disorder ◽  
Differentially Expressed Proteins ◽  
Healthy Control

Cannabis use has been growing recently and it is legally consumed in many countries. Cannabis has a variety of phytochemicals including cannabinoids, which might impair the peripheral systems responses affecting inflammatory and immunological pathways. However, the exact signaling pathways that induce these effects need further understanding. The objective of this study is to investigate the serum proteomic profiling in patients diagnosed with cannabis use disorder (CUD) as compared with healthy control subjects. The novelty of our study is to highlight the differentially changes proteins in the serum of CUD patients. Certain proteins can be targeted in the future to attenuate the toxicological effects of cannabis. Blood samples were collected from 20 male individuals: 10 healthy controls and 10 CUD patients. An untargeted proteomic technique employing two-dimensional difference in gel electrophoresis coupled with mass spectrometry was employed in this study to assess the differentially expressed proteins. The proteomic analysis identified a total of 121 proteins that showed significant changes in protein expression between CUD patients (experimental group) and healthy individuals (control group). For instance, the serum expression of inactive tyrosine protein kinase PEAK1 and tumor necrosis factor alpha-induced protein 3 were increased in CUD group. In contrast, the serum expression of transthyretin and serotransferrin were reduced in CUD group. Among these proteins, 55 proteins were significantly upregulated and 66 proteins significantly downregulated in CUD patients as compared with healthy control group. Ingenuity pathway analysis (IPA) found that these differentially expressed proteins are linked to p38MAPK, interleukin 12 complex, nuclear factor-κB, and other signaling pathways. Our work indicates that the differentially expressed serum proteins between CUD and control groups are correlated to liver X receptor/retinoid X receptor (RXR), farnesoid X receptor/RXR activation, and acute phase response signaling.

scholarly journals Effect of Glutamine Supplement Administration on the Reduction of Muscular Fatigue Post-Eccentric Exercise

2021 ◽  
Vol 55 (4) ◽  
pp. 275
Author(s):  
Afif Rusdiawan ◽  
Taufikkurrachman Taufikkurrachman
Keyword(s):  
Treatment Group ◽  
Muscle Strength ◽  
Knee Joint ◽  
Glutamine Supplementation ◽  
Control Group ◽  
Protein Levels ◽  
Drop Jumps ◽  
Post Test ◽  
The Mean ◽  
Leg Muscle

Eccentric activity can cause pain due to muscle damage and fatigue. Tired and damaged muscular state will degrade athletes' performance during a competition. Glutamine supplements are known to maintain plasma protein levels and can also improve muscle weakness due to inflammation that occurs after eccentric activity. The purpose of this study was to prove the effect of glutamine supplementation on the reduction of muscle fatigue after eccentric activity based on muscle strength and joint ROM. The subjects of this study were students of PJKR, IKIP Budi Utomo, who were randomly divided into 2 groups, the control group (K1) and treatment group (K2), each consisting of 22 respondents. The design of this research is randomized grsoup pre-test and post-test design. The eccentric activity performed was drop jumps on the bench with a height of 0.5 meters. Glutamine was administered orally after eccentric activity with a dose of 0.4 grams/kg BW in 450 ml water mineral 3 times (3 days). Measurement of Leg muscle strength was performed using Back and Leg Dynamometer by pulling with all the strength using leg muscles, whereas ROM measurements were measured using a goniometer performed on the knee joint in a passive way. The result of measurement obtained the mean of muscle strength of control group 63.7 ± 17.0 kg and treatment group 81.1 ± 17.0 kg at 72 hours. While result of ROM measurement obtained the mean of control group 124.3 ± 3.2 degrees and treatment group  131.7 ± 4.1 degrees at 72 hours. The analysis showed that glutamine administration in treatment group after eccentric activity increased leg muscle strength with p=0.000, and also increased knee joint ROM with p=0.000 at 72 hours after eccentric activity. In conclusion, glutamine administered with a dose of 0.4 gram/kg BW/day can increase leg muscle strength and knee joint ROM at 72 hours after eccentric activity.

scholarly journals Histological Evaluation of Brain Tissue in Dyslipidemic Rats Treated with Dietary Supplements Based on Amazonian Fruits

2021 ◽  
pp. 46-58
Author(s):  
Matheus Vinícius de Souza Carneiro ◽  
Ricardo de Queiroz Freitas ◽  
Lucas Baltar Rodrigues ◽  
Wenberger Lanza Daniel de Figueiredo ◽  
Geane Antiques Lourenço ◽  
...  
Keyword(s):  
Brain Tissue ◽  
Neuronal Damage ◽  
Female Rats ◽  
Histological Evaluation ◽  
Control Group ◽  
Neurotoxic Effect ◽  
Significant Difference ◽  
The Mean ◽  
The Brain ◽  
Amazonian Fruits

Aims: By using histological analysis, the study aims to evaluate the effect of a nutraceutical based on the Amazonian fruits of camu-camu (Myrciaria dubia (Kunth) Mc Vaugh), acai (Euterpe precatoria Mart.) and guarana (Paullinia cupana) on the brain tissue (hippocampus) of dyslipidemic rats. Methodology: Preclinical trials were conducted using male and female rats (n=30) of the Wistar strain (Rattus norvegicus) that were randomly divided into five groups (G) (n=6). G1 was control, G2 was induced to obesity with consumption of experimental feed (hypercaloric and hyperlipidic), G3 was induced to obesity with consumption of experimental feed and treated with simvastatin (50 mg/kg/day), and G4 and G5, which were induced to obesity with the consumption of experimental feed and supplemented with 100 mg/kg/day and 200 mg/kg/day of the formulation, respectively. The study period was 72 days, and, for 37 days, induction to obesity was performed with the experimental feed (hypercaloric and hyperlipidic). During the following weeks, for 35 days, after division of the groups, certain groups received, in parallel, treatment with simvastatin (G3) or supplementation with the nutraceutical (G4 and G5). Subsequently, histological slides of the brain tissue stained with violet cresyl were elaborated, photographed and analyzed. Results: No significant differences were observed between the mean of intact neurons among the experimental groups induced to obesity. The neurotoxic effect, evidenced by the significant difference between the mean of intact neurons between the control group and obesity-induced groups, corroborates the findings of neuronal damage and degenerative processes reported in the literature. Conclusion: The nutraceutical based on Amazonian fruits was not able to prevent the neurotoxic effect arising from the hyperlipidic and hypercaloric diet, and therefore did not present a neuroprotective effect in Wistar rats under the conditions established in the experiment.

scholarly journals Vitamin D in acutely ill patients

2018 ◽  
Vol 46 (10) ◽  
pp. 4246-4257 ◽  
Author(s):  
Ifigenia Kostoglou-Athanassiou ◽  
Eleni Pantazi ◽  
Sofoklis Kontogiannis ◽  
Dimitrios Kousouris ◽  
Iordanis Mavropoulos ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Inverse Relationship ◽  
Control Group ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein ◽  
Control Subjects ◽  
Healthy Control ◽  
The Mean

Objective To investigate 25(OH)D3 levels and their relationship to survival in a cohort of acutely ill patients on admission to an intensive care unit. Methods This study enrolled acutely ill patients at admission to an intensive care unit and a group of sex- and age-matched healthy control subjects. The 25(OH)D3 levels were measured using an enzyme immunoassay. C-reactive protein and procalcitonin levels were also measured using immunoassays. Results A total of 50 acutely ill patients and 50 healthy control subjects were enrolled in the study. The mean ± SEM 25(OH)D3 levels were significantly lower in the acutely ill patients compared with the control group (11.74 ± 0.88 ng/ml versus 24.66 ± 1.60 ng/ml, respectively). The 25(OH)D3 levels were not related to survival. An inverse relationship was observed between 25(OH)D3 levels and C-reactive protein levels. A weak inverse relationship was also observed between 25(OH)D3 levels and procalcitonin levels. Conclusions The 25(OH)D3 levels were decreased in acutely ill patients admitted to an intensive care unit compared with healthy control subjects. 25(OH)D3 levels may be inversely related to C-reactive protein and procalcitonin levels.

scholarly journals Psychosocial functioning among regular cannabis users with and without cannabis use disorder

2017 ◽  
Vol 48 (11) ◽  
pp. 1853-1861 ◽  
Author(s):  
Katherine T. Foster ◽  
Brooke J. Arterberry ◽  
William G. Iacono ◽  
Matt McGue ◽  
Brian M. Hicks
Keyword(s):  
Young Adulthood ◽  
Psychosocial Functioning ◽  
Study Groups ◽  
The United States ◽  
Cannabis Use ◽  
Control Group ◽  
Cannabis Use Disorder ◽  
High Agreement ◽  
Psychosocial Impairment ◽  
Adolescence And Young Adulthood

AbstractBackgroundIn the United States, cannabis accessibility has continued to rise as the perception of its harmfulness has decreased. Only about 30% of regular cannabis users develop cannabis use disorder (CUD), but it is unclear if individuals who use cannabis regularly without ever developing CUD experience notable psychosocial impairment across the lifespan. Therefore, psychosocial functioning was compared across regular cannabis users with or without CUD and a non-user control group during adolescence (age 17; early risk) and young adulthood (ages 18–25; peak CUD prevalence).MethodWeekly cannabis users with CUD (n = 311), weekly users without CUD (n = 111), and non-users (n = 996) were identified in the Minnesota Twin Family Study. Groups were compared on alcohol and illicit drug use, psychiatric problems, personality, and social functioning at age 17 and from ages 18 to 25. Self-reported cannabis use and problem use were independently verified using co-twin informant report.ResultsIn both adolescence and young adulthood, non-CUD users reported significantly higher levels of substance use problems and externalizing behaviors than non-users, but lower levels than CUD users. High agreement between self- and co-twin informant reports confirmed the validity of self-reported cannabis use problems.ConclusionsEven in the absence of CUD, regular cannabis use was associated with psychosocial impairment in adolescence and young adulthood. However, regular users with CUD endorsed especially high psychiatric comorbidity and psychosocial impairment. The need for early prevention and intervention – regardless of CUD status – was highlighted by the presence of these patterns in adolescence.

Importance of N-terminal pro-brain natriuretic peptide in monitoring acute rheumatic carditis

2013 ◽  
Vol 25 (1) ◽  
pp. 110-114 ◽  
Author(s):  
Feyza Esen ◽  
Mustafa Argun ◽  
Özge Pamukçu ◽  
Abdullah Ozyurt ◽  
Ali Baykan ◽  
...  
Keyword(s):  
Brain Natriuretic Peptide ◽  
Left Atrium ◽  
Natriuretic Peptide ◽  
Control Group ◽  
Healthy Children ◽  
Rheumatic Carditis ◽  
Laboratory Findings ◽  
Cardiac Inflammation ◽  
Protein Levels ◽  
The Mean

AbstractPurposeTo detect the relationship of N-terminal pro-brain natriuretic peptide levels with clinical and laboratory findings by measuring them at diagnosis, during, and after treatment in children with acute rheumatic carditis.MethodA total of 40 children including 20 acute rheumatic carditis patients aged between 5 and 16 years 20 healthy children as controls were included in the study. Blood was drawn from patients at diagnosis and in the first week, first month and third month after treatment in order to detect pro-brain natriuretic peptide, C-reactive protein levels and erythrocyte sedimentation rates. All patients underwent echocardiography.ResultsThe N-terminal pro-brain natriuretic peptide levels of children with acute rheumatic carditis were significantly higher than those of the control group at diagnosis and during treatment (p<0.05). Echocardiographic evaluation of acute rheumatic carditis patients revealed that the left atrium diameter continued to decrease during the study and that the mean left atrium diameters measured at diagnosis and in the first week were statistically higher than the mean left atrium diameters measured in the third month. There was significant correlation between left atrium diameters at diagnosis and in the first month and N-terminal pro-brain natriuretic peptide levels during the same periods in the patient group.ConclusionPrevious studies have used N-terminal pro-brain natriuretic peptide levels as a marker of enlargement of the left atrium, whereas in this study we want to emphasise its role as a marker of inflammation. This increase was significantly correlated with enlargement in the left atrium. N-terminal pro-brain natriuretic peptide levels were found to be a valuable determinant in indicating cardiac inflammation and haemodynamics.

scholarly journals Effect of Glutamine Supplement Administration on the Reduction of Muscular Fatigue Post-Eccentric Exercise

2020 ◽  
Vol 55 (4) ◽  
pp. 275
Author(s):  
Afif Rusdiawan ◽  
Taufikkurrachman Taufikkurrachman
Keyword(s):  
Treatment Group ◽  
Muscle Strength ◽  
Knee Joint ◽  
Glutamine Supplementation ◽  
Control Group ◽  
Protein Levels ◽  
Drop Jumps ◽  
Post Test ◽  
The Mean ◽  
Leg Muscle

Eccentric activity can cause pain due to muscle damage and fatigue. Tired and damaged muscular state will degrade athletes' performance during a competition. Glutamine supplements are known to maintain plasma protein levels and can also improve muscle weakness due to inflammation that occurs after eccentric activity. The purpose of this study was to prove the effect of glutamine supplementation on the reduction of muscle fatigue after eccentric activity based on muscle strength and joint ROM. The subjects of this study were students of PJKR, IKIP Budi Utomo, who were randomly divided into 2 groups, the control group (K1) and treatment group (K2), each consisting of 22 respondents. The design of this research is randomized grsoup pre-test and post-test design. The eccentric activity performed was drop jumps on the bench with a height of 0.5 meters. Glutamine was administered orally after eccentric activity with a dose of 0.4 grams/kg BW in 450 ml water mineral 3 times (3 days). Measurement of Leg muscle strength was performed using Back and Leg Dynamometer by pulling with all the strength using leg muscles, whereas ROM measurements were measured using a goniometer performed on the knee joint in a passive way. The result of measurement obtained the mean of muscle strength of control group 63.7 ± 17.0 kg and treatment group 81.1 ± 17.0 kg at 72 hours. While result of ROM measurement obtained the mean of control group 124.3 ± 3.2 degrees and treatment group  131.7 ± 4.1 degrees at 72 hours. The analysis showed that glutamine administration in treatment group after eccentric activity increased leg muscle strength with p=0.000, and also increased knee joint ROM with p=0.000 at 72 hours after eccentric activity. In conclusion, glutamine administered with a dose of 0.4 gram/kg BW/day can increase leg muscle strength and knee joint ROM at 72 hours after eccentric activity.

scholarly journals Expression of S100 calcium-binding protein A8 in peripheral blood of patients with preeclampsia during pregnancy

2019 ◽  
Vol 17 ◽  
pp. 205873921985852
Author(s):  
Xiaoyun Li ◽  
Fangzheng Cheng ◽  
Guangchao Cao
Keyword(s):  
Calcium Binding ◽  
Binding Protein ◽  
Calcium Binding Protein ◽  
Severe Preeclampsia ◽  
Inflammatory Factors ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Control Groups ◽  
S100 Calcium Binding Protein ◽  
Tnf Α

A total of 30 late onset severe preeclampsia (LS-PE) patients and 30 early onset severe preeclampsia (ES-PE) patients were selected as Experimental group, and 30 normal pregnant were selected as Control group. Expression of S100 calcium-binding protein A8 (S100A8) mRNA was detected by reverse transcription polymerase chain reaction (RT-PCR). Enzyme-linked immunosorbent assay (ELISA) was used to detect expression of S100A8 protein and inflammatory factors. Levels of uric acid (UA) and creatinine (CRE) were measured using an automatic biochemical analyzer. Urinary protein (UPRO) content was measured using biuret colorimetry. S100A8 levels were significantly higher in experimental groups than in control groups at mRNA and protein levels ( P < 0.05). Significantly increased contents of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-12, UA, CRE, and UPRO, and decreased level of IL-10 were found in experimental groups than in control groups ( P < 0.05). Compared with patients with ES-PE, significantly higher levels of TNF-α, IL-12, IL-6, UA, CRE, and UPRO, and lower level of IL-10 were found in patients with LS-PE. S100A8 plays pivotal roles in the development of preeclampsia through the interactions with other inflammatory factors.

Sign in / Sign up

Export Citation Format

Share Document